Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men.

Abstract

Ghrelin is a growth hormone-releasing peptide secreted by the stomach with potent effects on appetite. Experimental and clinical studies indicate that ghrelin also influences cardiovascular regulation and metabolic function and mediates behavioral responses to stress. We investigated the effects of ghrelin on blood pressure (BP), sympathetic nervous system activity, and mental stress responses in lean (n=13) and overweight or obese (n=13) individuals. Subjects received an intravenous infusion of human ghrelin (5 pmol/kg per minute for 1 hour) and saline in a randomized fashion. Ghrelin decreased systolic (-6 and -11 mm Hg) and diastolic BP (-8 mm Hg for both), increased muscle sympathetic nervous system activity (18±2 to 28±3 bursts per min, P<0.05 and from 21±2 to 32±3 bursts per min, P<0.001) in lean and overweight or obese subjects, respectively, without a significant change in heart rate, calf blood flow, or vascular resistance. Ghrelin induced a rise in plasma glucose concentration in lean individuals (P<0.05) and increased cortisol levels in both groups (P<0.05). Stress induced a significant change in mean BP (+22 and +27 mm Hg), heart rate (+36 and +29 bpm), and muscle sympathetic nervous system activity (+6.1±1.6 and +6.8±2.7 bursts per min) during saline infusion in lean and overweight or obese subjects, respectively. During ghrelin infusion, the changes in BP and muscle sympathetic nerve activity in response to stress were significantly reduced in both groups (P<0.05). In conclusion, ghrelin exerts unique effects in that it reduces BP and increases muscle sympathetic nervous system activity and blunts cardiovascular responses to mental stress. These responses may represent a combination of peripheral (baroreflex-mediated) and central effects of ghrelin.

• Authors: Elisabeth Lambert, Gavin Lambert, Carolina Ika-Sari, Tye Dawood, Katie Lee, Reena Chopra, Nora Straznicky, Nina Eikelis, Sara Drew, Alan Tilbrook, John Dixon, Murray Esler, Markus P Schlaich
• Journal: Hypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 58 Issue 1 Pg. 43-50 (Jul 2011) ISSN: 1524-4563 [Electronic] United States
• PMID: 21502567 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Ghrelin

Topics

• Adult
• Blood Pressure (drug effects)
• Follow-Up Studies
• Ghrelin (administration & dosage)
• Heart Rate (drug effects)
• Humans
• Infusions, Intravenous
• Male
• Overweight (complications, physiopathology)
• Stress, Psychological (complications, physiopathology, prevention & control)
• Sympathetic Nervous System (drug effects, physiopathology)
• Thinness (complications, physiopathology)
• Vascular Resistance (drug effects)
• Young Adult